R
Radical Numerics
AI-powered scientific world models for complex systems.
About Radical Numerics
Radical Numerics is a Menlo Park AI research lab spun out of Stanford that builds multimodal foundation models for biology—spanning DNA, RNA, proteins and related modalities—to enable generative genomics for medicine and biodefense. Co-founded by Eric Nguyen, Michael Poli, Stefano Massaroli and Armin, the team previously released Evo and Evo 2, open biological sequence models trained across millions of genomes that other researchers have used to design a functional synthetic bacteriophage. Its preview genome language model Omnii uses a multi-hybrid architecture with a two-million-token context window, multimodality and mid-/post-training alignment, and is being piloted for early cancer detection with a diagnostics partner and for biosurveillance with a U.S. national laboratory. In June 2026 Radical Numerics launched with a $50 million seed round led by Emergence Capital, with Obvious Ventures, Triatomic Capital, First Spark Ventures and Factory, to scale compute (including an NVIDIA Blackwell data centre), architecture research and dual-mandate work in human health and biodefense. Sources: Emergence Capital 15 Jun 2026; company blog; GenomeWeb; radicalnumerics.ai.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2025
- Headquarters
- San Francisco, United States
- Employees
- 16
- Open positions
- 11
- Dealroom signal
- 60.2/100
- Industry
- Health
- Sector
- Health, Drug Development, Genetics and genomics, Generative AI
- Technology
- Artificial Intelligence
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEEDOther financing | Jun 2026 | $50M | $200M | Patrick Collison · Obvious Ventures · Factory · First Spark Ventures | ↗ |
Growth signals
Latest recorded traffic for Radical Numerics is 19K monthly website visits, up 493.8% over the last three months.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
DataInformation TechnologyAI-powered drug discovery and clinical validation platform. |
China | Operational | — | $2.8M | $28M |
Proxima BioFormerly VantAI. Proximity therapeutics hijacking cellular machinery for protein degradation |
New York City, United States | Operational | |||
LabNinjaAI automation for targeted, replication-ready experimental data |
— | Operational | |||
SilicoScientiaAI-powered computational platform for drug discovery. |
India | Operational | |||
GalagosAI-powered bioinformatics platform for complex biological data. |
Hamburg, Germany | Operational | |||
Pattern AgentixAI-native bioscience platform for accelerating scientific discovery. |
Canada | Operational | |||
EpsilicoGenerative AI for protein therapy design |
Berlin, Germany | Operational | |||
Cambridge Precision Dosing Inc.Predictive modeling for personalized patient drug dosing. |
Cambridge, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
Emergence
Patrick Collison
Obvious Ventures
Factory
First Spark Ventures
Triatomic Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Radical Numerics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Radical Numerics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







